TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
UTB medicin AB
Closing information (x1000 EUR)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
113
|
94 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
83
|
64 | |
EBITDA |
81
|
64 | |
Total assets |
133
|
93 | |
Current assets |
119
|
86 | |
Current liabilities |
34
|
33 | |
Equity capital |
99
|
60 | |
- share capital |
9
![]() |
9 | |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
74.4%
|
64.5% | |
Turnover per employee |
113
|
94 | |
Profit as a percentage of turnover |
73.5%
|
68.1% | |
Return on assets (ROA) |
62.4%
|
68.8% | |
Current ratio |
350.0%
|
260.6% | |
Return on equity (ROE) |
83.8%
|
106.7% | |
Change turnover |
19
|
90 | |
Change turnover % |
-6%
|
20%
|
1998% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.